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Objective: EphrinA2- EphA2 and ephrinB2- EphB4 critically engage in bidirectional sig-
nalling to modulate alveolar bone remodelling. The present study aimed to investigate 
the effects of lipopolysaccharides (LPS) derived from Porphyromonas gingivalis on 
ephrin/Eph signalling in periodontal ligament fibroblasts (PDLFs).
Material and Methods: The primary cultured PDLFs were incubated in the absence (as 
a control) or presence of P. gingivalis LPS at 0.001- 10 μg/mL for 24 hours. The PDLFs 
were then stimulated with P. gingivalis LPS at the optimal concentration (0.1 μg/mL) 
for different periods (6- 48 hours). The expression of ephrinA2, ephrinB2, EphA2 and 
EphB4 was assessed by quantitative reverse- transcription real- time polymerase chain 
reaction and western blotting. The osteoblastic markers alkaline phosphatase, osteoc-
alcin and Runt- related transcription factor 2 (Runx2), and the osteoclastogenesis- 
related factors receptor activator of nuclear factor kappa- B ligand (RANKL) and 
osteoprotegerin were also evaluated.
Results: The ephrinA2 and EphA2 expression was upregulated and EphB4 expression 
was downregulated by stimulation of P. gingivalis LPS. EphrinA2 mRNA expression in 
the PDLFs was significantly upregulated from 12 to 48 hours (P<.05), whereas EphA2 
exhibited no change for the first 24 hours, after which there was a significant increase 
at 48 hours (P<.05). EphB4 exhibited lower mRNA expression at 12 and 24 hours than 
did the control (P<.05), but the change was insignificant at 48 hours. In contrast, the 
expression of ephrinB2 remained unchanged. The expressions of ephrinA2, EphA2, 
ephrinB2 and EphB4 at the protein level showed a similar pattern to that at the mRNA 
level. The expression of Runx2 and osteocalcin significantly decreased, whereas that 
of RANKL/osteoprotegerin increased.
Conclusion: The present study suggest that P. gingivalis LPS would contribute to a 
dysregulation of bone remodelling, whereby ephrinA2/EphA2 expression is stimu-
lated and EphB4 expression is inhibited.
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1  | INTRODUCTION
The periodontium, a specialized tissue that surrounds the tooth root, 
is composed of the gingiva, the periodontal ligament (PDL), cementum 
and alveolar bone. As a part of the soft tissue in the periodontium, the 
PDL is a group of highly cellular, fibrous and connective tissues that 
attaches the teeth to the surrounding alveolar bone via the cementum. 
It is reported that the PDL has the capacity to secrete the biochemical 
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substances involved in the regulation of alveolar bone remodelling.1 
In the mechanism of bone- related activity, Runt- related transcription 
factor 2 (Runx2) is associated with osteoblast differentiation.2 Alkaline 
phosphatase (ALP) is closely associated with bone mineralization, and 
together with osteocalcin, acts as a hallmark of osteoblast differentia-
tion in the regulation of osteogenesis. In contrast, the receptor activa-
tor of nuclear factor kappa- B ligand (RANKL)- osteoprotegerin (OPG) 
axis is known to be a master factor regulating osteoclast formation.3 
Under this physiological condition, the maintenance of alveolar bone is 
achieved through a dynamic equilibrium between bone deposition and 
resorption. However, the balance of this process is disturbed by the 
presence of chronic periodontal inflammation, resulting in activation 
of osteoclastogenic factors and subsequent bone loss.4
Recent research has found that bone cell interactions are modu-
lated by bidirectional signalling, ephrin ligands and Eph receptors.5 The 
receptor tyrosine kinases of the Eph family interact with the ephrin 
ligands at the cell surface because both are transmembrane proteins.6 
Eph and ephrin molecules function as a receptor- ligand pair in cell- cell 
communication processes, triggering bidirectional signal transduction; 
namely, forward signalling via Ephs and reverse signalling via ephrin 
ligands.7 Both ephrins and Ephs are divided into two subclasses, A and 
B. Recent studies have indicated that various bone cells express ephrin 
ligands and Eph receptors, of which ephrinB2- EphB4 and ephrinA2- 
EphA2 differentially regulate the bone biology.8,9 In that way, the bi-
directional signalling between osteoclastic ephrinB2 and osteoblastic 
EphB4 suppresses osteoclastogenesis and enhances osteogenesis in 
osteoclast- osteoblast communication. In contrast, reverse signalling 
via ephrinA2 and forward signalling via EphA2 reinforce osteoclastic 
bone resorption and inhibit osteoblastic bone formation.5 Studies on 
ehprin- Eph largely focused on bone cells until 2011, when Diercke 
et al.10,11 reported that periodontal ligament fibroblasts (PDLFs) also 
express ephrin/Eph molecules. Their research also revealed that 
ephrinB2- EphB4 and ephrinA2- EphA2 signalling are particularly im-
portant for the regulation of bone remodelling during orthodontic 
force loading between PDLFs and osteoblasts. Beyond the aforemen-
tioned studies by Diercke et al., little research has elaborated on the 
ephrin/Eph signalling in PDL and alveolar bone. Therefore, further in-
vestigation of this bidirectional signalling in PDL is worthwhile, partic-
ularly its role in periodontal inflammation when the bone remodelling 
balance has been broken and the osteoclastogenic factors and subse-
quent bone loss are activated. The results are expected to clarify the 
mechanism and shed light on the prevention and treatment of peri-
odontal inflammation diseases.
It is well established that periodontitis, or inflammation of the peri-
odontium, is triggered by pathogenic bacteria (mainly gram- negative 
anaerobes such as Porphyromonas gingivalis12 in the biofilm. It is charac-
terized by the pathologic destruction of tooth- supporting tissues, which 
can cause loss of the tooth. Lipopolysaccharides (LPS), the major element 
in the outer membranes of gram- negative bacteria, act as prototypical 
endotoxins. LPS derived from P. gingivalis have been shown to promote 
the secretion of periodontal disease- related proinflammatory cytokines 
by PDLFs.13 LPS are also involved in RANKL and OPG- regulated os-
teoclast formation and bone resorption in PDLFs,14 and their inhibitory 
effect on the osteoblastic differentiation of osteoprogenitor cells.15 LPS 
are thus believed important pathogens in periodontitis that can lead to 
alveolar bone resorption in most advanced cases. Although LPS have 
been extensively studied and shown to contribute to the pathogenesis 
of periodontal disease,16 their possible effects on periodontitis bone 
resorption via ephrin/Eph signalling are still poorly understood. PDLFs 
are the dominant cell population in the PDL, and have been shown to 
express high levels of ALP activity and to secrete RANKL and OPG, in-
dicating that they participate in bone remodelling.17 Therefore, it has 
been argued that the PDL plays a crucial role in alveolar bone metab-
olism. Collectively, we hypothesized that ephrin/Eph expression is also 
regulated by LPS stimuli in PDLFs. This study was therefore designed to 
extend the roles of the ephrinB2- EphB4 and ephrinA2- EphA2 systems 
to include PDLFs during inflammatory events.
2  | MATERIAL AND METHODS
2.1 | Primary cell culture
Human PDLFs were cultured using the method described in earlier 
research with slight modifications.18 Healthy premolars extracted for 
orthodontic purposes were collected from four healthy donors (aged 
13.5±1.7 years) who gave signed informed consent according to 
the Institutional Review Board of the University of Hong Kong (IRB: 
UW13- 120). Briefly, to obtain primary PDLF tissue fragments of the 
PDL were isolated from the middle third surface of the tooth root 
with a scalpel. The cells were cultured in modified Eagle’s medium- 
alpha, supplemented with 10% foetal bovine serum and 1% antibiotics 
(100 U/mL penicillin and 100 μg/mL streptomycin) and incubated at 
37°C in a humidified atmosphere with 5% CO2. The culture medium 
was replaced every 3 days after passaging, and the fifth passage cells 
cultured in monolayers were ready to be used for all experiments.
2.2 | Lipopolysaccharide challenge of periodontal 
ligament fibroblasts
After reaching confluence, the PDLFs were seeded at a density of 
5×104 cells per well in a six- well plate. At 80% confluence, the cells were 
starved for 12 hours in modified Eagle’s medium alpha without foetal 
bovine serum and then treated with ultrapure LPS derived from P. gin-
givalis (InvivoGen, San Diego, CA, USA). To test the dose- dependent 
effects, the PDLFs were cultured in the presence of P. gingivalis LPS 
at concentrations of 0.001, 0.01, 0.1, 1 and 10 μg/mL for 24 hours. 
The concentrations of P. gingivalis LPS (0.001- 10 μg/mL) we selected, 
which could be refined to different experiment protocols, are based on 
previous research regarding the in- vitro PDLF cultures.19-21 To inves-
tigate the time- dependent effects, P. gingivalis LPS of the optimal con-
centration (0.1 μg/mL) was used to stimulate the PDLFs for different 
experimental periods (6, 12, 24 and 48 hours). Untreated PDLFs served 
as the control. The heterogeneity of P. gingivalis LPS lipid A structure 
can be influenced by hemin concentration and temperature,22,23 thus 
presents two different isoforms including PgLPS1690 and PgLPS1435/1449 
that differentially mediate the expression of immuno- inflammatory 
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cytokines.24,25 The P. gingivalis LPS used in the present study (LPS- PG 
Ultrapure, InvivoGen Catalogue number: tlrl- ppglps) is a highly puri-
fied preparation of LPS from the gram- negative bacteria P. gingivalis, 
which is a generally used one obtained from InvivoGen and used in 
other studies.26-28 However, the isoform and molecular weight of the 
P. gingivalis LPS have not been specified by the manufacturer.
2.3 | Quantitative reverse- transcription real- time 
polymerase chain reaction
Total cellular messenger RNA (mRNA) was extracted from the PDLFs 
using an RNeasy Mini Kit (Qiagen, Hilden, Germany), and its concen-
tration was determined by the absorbance measurement at 260 nm. 
Complementary DNA (cDNA) was then synthesized from the mRNA 
using the SuperScript III First- Strand Synthesis System (Invitrogen, 
Carlsbad, CA, USA). The concentration of mRNA used for quantitative 
reverse transcription- polymerase chain reaction (qRT- PCR) was 80- 
150 ng/μL. The concentration of cDNA after RT was diluted in a 1:4 
ratio. To analyse the relative gene expression level of the target genes, 
qRT- PCR was performed with SYBR Green as a fluorescent dye in a 
StepOnePlus Real- Time PCR System (Applied Biosystems, Carlsbad, 
CA, USA). Glyceraldehyde- 3- phosphate dehydrogenase was used as 
the house- keeping gene for endogenous control and for calculating 
the target gene expression. The expressions of ephrin B2, EphB4, eph-
rinA2 and EphA2 were assessed. To gain a more detailed insight into 
the mechanism of LPS- induced bone remodelling at the molecular level, 
the expression of some osteoblast differentiation genes (Runx2, ALP 
and osteocalcin) and osteoclastogenesis- related genes (RANKL and 
OPG) in PDLFs were also monitored using qRT- PCR after a 24 hour 
challenge with LPS (0.1 μg/mL). All of the primer sequences for the tar-
get genes are listed in Table 1. The amplification reactions were imple-
mented in 96- well plates with a mixture volume of 20 μL that contained 
1 μL cDNA and 10 μL Power SYBR Green PCR Master Mix (Applied 
Biosystems) in each well with the following programme: initial heating 
to 95°C for 10 minutes, followed by 40 cycles of denaturation at 95°C 
for 15 seconds and annealing and extension at 60°C for 1 minutes.
2.4 | Western blotting
The PDLFs were collected using an RIPA buffer (Thermo Scientific, 
Rockford, IL, USA) containing a protease inhibitor cocktail. The Pierce 
BCA Protein Assay Kit (Thermo Scientific) was used for total protein 
quantification. A lysate with 25 μg (for ephrinB2 and ephrinA2 de-
tection), 30 μg (for EphA2 detection) or 35 μg (for EphB4 detection) 
of protein was then fractionated on 10% sodium dodecyl sulphate- 
polyacrylamide gel and transferred on to a nitrocellulose membrane. 
The membranes were blocked for 1 hour at room temperature with 
5% non- fat milk in TBS- T (10 mM Tris, 100 mM NaCl and 0.1% 
Tween20), after which they were probed overnight at 4°C with rab-
bit anti- ephrinB2 monoclonal antibody (1:1000; Abcam, Cambridge, 
UK), rabbit anti- EphB4 monoclonal antibody (1:500; Cell Signaling 
Technology, Danvers, MA, USA), rabbit ephrinA2 polyclonal antibody 
(1:500; Abcam) or rabbit anti- EphA2 monoclonal antibody (1:1000; 
Cell Signaling Technology). β- Actin (1:1000; Cell Signaling Technology) 
served as the internal control. The densities of western blotting bands 
were measured by ImageJ (an open source Java image processing pro-
gram inspired by NIH Image, https://imagej.nih.gov/ij/).
2.5 | Statistical analysis
The experiments were performed in triplicate and the results were ex-
pressed as means±standard deviation (SD). The data were compared 
with independent two- tailed t tests. A P value of .05 was considered 
to show statistical significance.
3  | RESULTS
3.1 | mRNA expressions of ephrinB2- EphB4 and 
ephrinA2- EphA2 in a P. gingivalis lipopolysaccharide 
dose- dependent manner
After culturing with P. gingivalis LPS at different concentrations 
for 24 hours, the mRNA expression levels of ephrinB2- EphB4 and 
TABLE  1 Primer sequences of the target genes for quantitative reverse transcription- polymerase chain reaction
Gene name Forward sequence (5′→3′) Reverse sequence (5′→3′) Sequence ID
Primer location 
(Fw- Rv)
ephrinA2 CAATAAGCTCGTGTCGTCTGTCA TAGTGGTTCCCTCCCTTTTGTC NM_001405.3 1725- 1824
EphA2 TCAAGGACCAGGTGAACACTGT AGGGAGGCCACTCTGTTTCTTC NM_004431.3 3049- 3148
ephrinB2 TCCCTGGTCACCCGACTTT ACTGTAACACCCCAAATCCATAGAC NM_004093.3 3780- 3879
EphB4 GTGCCTTGGTCATCCCACAT ACCAACTACCGCCCTTTTCA NM_004444.4 4141- 4240
RANKL AAAGCTGACATTGCCAAAAAGG TTTGCGGCACTTGTGGAA NM_003701.3 1938- 2037
OPG GCCCTGACCACTACTACACAGACA TTGCACTCCTGCTTGACGTACT NM_002546.3 517- 616
Runx2 ACTGGCGCTGCAACAAGAC TCATCGTTACCCGCCATGA NM_001024630.3 596- 695
OCN CGGTGCAGAGTCCAGCAAA GGCTCCCAGCCATTGATACA NM_199173.5 348- 447
ALP CTGATGTGGAGTATGAGAGTGAC CAGATGAAGTGGGAGTGCTTGT NM_000478.5 959- 1073
GAPDH TCCCTGAGCTGAACGGGAAG GGAGGAGTGGGTGTCGCTGT NM_002046.5 850- 1067
Annotations for target genes: ALP, alkaline phosphatase; Fw- Rv, forward- reverse; GAPDH, glyceraldehyde- 3- phosphate dehydrogenase; OCN,  osteocalcin; 
OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor kappa- B ligand; Runx2, runt- related transcription factor 2.
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ephrinA2- EphA2 in the PDLFs were assessed. EphB4 expression ex-
hibited a significant downward trend (P<.05) with unaltered ephrinB2 
expression, whereas ephrinA2 was significantly up- regulated (P<.05) 
and accompanied by unaffected EphA2 in LPS- stimulated PDLFs. The 
results of the qPCR showed no striking dose- dependent relation-
ship among these changes, except that the expression of ephrinA2 
reached its peak when the P. gingivalis LPS concentration was 0.1 μg/
mL (P<.01) (Figure 1). A P. gingivalis LPS concentration of 0.1 μg/mL 
was therefore considered optimal for the subsequent experiments.
3.2 | Time- dependent mRNA Expression of 
ephrinB2- EphB4 and ephrinA2- EphA2
EphB4 expressed lower levels of mRNA at 12 hours (P<.05) and 
24 hours (P<.01) than did the control group, but the change was insig-
nificant at 48 hours (Figure 2D). The expression of ephrinB2 remained 
unchanged with different concentrations of P. gingivalis LPS over the 
treatment time (Figures 1C and 2C).
EphrinA2 expression significantly increased in a time- dependent 
manner from 12 to 24 hours (P<.05) and slightly decreased at 
48 hours, but remained markedly higher than in the control group 
(P<.01) (Figure 2A). The expression of EphA2 showed no change 
over the first 24 hours, after which a significant increase was seen at 
48 hours (P<.05) (Figure 2B).
3.3 | Expression of ephrinB2- EphB4 and ephrinA2- 
EphA2 at the protein level
The results of western blotting confirmed the findings of the mRNA 
expression level. The changing tendency at the mRNA and protein lev-
els was the same but was observed at different treatment time points. 
The protein expressions of ephrinA2 and EphA2 were increased at 
24 and 72 hours, respectively (Figure 3), whereas the upregulation 
of ephrinA2 mRNA expression was found from 12 to 48 hours and 
EphA2 was upregulated at 72 hours (Figure 2B). The downregula-
tion of EphB4 protein expression was not observed until 72 hours 
(Figure 3), whereas its mRNA expression decreased from 12 to 
24 hours after stimulation with P. gingivalis LPS (Figure 2D). Similar to 
the result at the mRNA level, ephrinB2 expression showed no signifi-
cant difference at the protein level (Figure 3). In particular, the protein 
expression was first measured for 24 and 48 hours, yet the level of 
EphA2 and EphB4 had no significant changes during these periods. 
Assuming that the post- transcription modification and translation 
process may affect the timing of mRNA and protein expression, we 
extend the treatment time to 72 hours. As expected, both the expres-
sions of EphA2 and EphB4 were found the same varying tendency as 
the gene expression did. As the protein expression of ephrinA2 went 
down to the control level again after 48 hours of stimulation, and that 
of ephrinB2 was unchanged at the mRNA level from 24 to 48 hours, 
F IGURE  1 Dose- dependent effects of Porphyromonas gingivalis LPS on ephrinA2- EphA2 and ephrinB2- EphB4 mRNA expression in 
periodontal ligament fibroblasts determined by quantitative reverse transcription- polymerase chain reaction. Expression of ephrinA2 (A), EphA2 
(B), ephrinB2 (C) and EphB4 (D) in LPS- stimulated periodontal ligament fibroblasts when cells were treated with P. gingivalis LPS at five different 
concentrations (0.001, 0.01, 0.1, 1 and 10 μg/mL) for 24 h. Data were presented as mean±SD. *P<.05, **P<.01, ***P<.001 vs control. LPS, 
lipopolysaccharide
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their expression at protein levels within 48 hours has confirmed that 
at mRNA levels, thus the protein expression of ephrinA2 and ephrinB2 
after 48 hours were not further assessed.
3.4 | Expression of osteoblastic markers (alkaline 
phosphatase, osteocalcin and Runt- related 
transcription factor 2) and osteoclastogenesis- related 
factors (receptor activator of nuclear factor kappa- B 
ligand and osteoprotegerin)
For the osteoblastic markers, the PDLFs expressed decreasing mRNA 
of Runx2 (P<.01) and osteocalcin (P<.001) after stimulation with 
0.1 μg/mL P. gingivalis LPS for 24 hours. No significant variation in 
ALP was found (Figure 4). In contrast, the RANKL/OPG ratio was 
 upregulated significantly (P<.001) with decreased OPG (P<.001).
4  | DISCUSSION
In the present study, we investigated the ephrin/Eph expression 
regulated by LPS stimuli in human PDLFs. It is known that perio-
dontitis is caused by bacterial colonies and their metabolites, par-
ticularly LPS, accompanied by a host- mediated immune response 
against these microorganisms and a progressive loss of alveolar 
bone. Accumulating evidence indicates that ephrins and Ephs affect 
bone homeostasis both in normal conditions and in a range of path-
ologic conditions such as osteoporosis and cancer- induced bone 
disease.29 Although some studies have assessed through the regula-
tion on ephrin/Eph signalling that LPS are involved,30,31 they have 
largely evaluated the lung injury model30 or osteoblast- osteoclast 
co- culture systems.31 The regulation on ephrin/Eph signalling in 
human PDL with LPS stimulation has not been assessed. Therefore, 
in this study, we investigated the dose- and time- dependent ef-
fects of P. gingivalis LPS on human PDL fibroblasts by evaluating 
ephrinB2- EphB4 and ephrinA2- EphA2 expression related to path-
ologic bone resorption. We found that P. gingivalis LPS enhanced 
ephrinA2 and EphA2 expression and attenuated EphB4 expression 
in PDLFs. Besides, several studies evaluated the in- vivo amount of 
LPS in the case of periodontal disease, eg, the serum LPS concentra-
tion is approximately 1.0 ng/mL in patients with severe periodon-
titis.32 Another example33 has shown about 0.4 endotoxin unit/mL 
of LPS in the gingival crevicular fluid of a periodontitis rat model. 
However, these data are not comparable to the LPS dose used in 
in- vitro studies as the LPS contained in the serum is pretty low and 
that measured in gingival crevicular fluid is presented with the ac-
tivity of the endotoxin. Thus, we referred to the corresponding in- 
vitro research19-21 and chose the most commonly used quantities of 
P. gingivalis LPS for our experiment planning.
F IGURE  2 Time- dependent effects of Porphyromonas gingivalis LPS on ephrinA2- EphA2 and ephrinB2- EphB4 mRNA expression in 
periodontal ligament fibroblasts determined by quantitative reverse transcription- polymerase chain reaction. Expression of ephrinA2 (A) and 
EphA2 (B), ephrinB2 (C) and EphB4 (D) in LPS- stimulated periodontal ligament fibroblasts when cells were treated with 0.1 μg/mL P. gingivalis 
LPS for 6, 12, 24 and 48 h. Data were presented as mean±SD. *P<.05, **P<.01 vs control. LPS, lipopolysaccharide
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The results of the qPCR revealed no striking dose- dependent re-
lationship among these changes, except that the expression of eph-
rinA2 reached its peak when the P. gingivalis LPS concentration was 
0.1 μg/mL. We further treated the cells with 0.1 μg/mL P. gingivalis 
LPS from 6 to 48 hours. It is interesting to find that the upregula-
tion of EphA2 (48 hours) lagged behind that of ephrinA2 (from 12 
to 48 hours) at the transcriptional level, which suggests a disruption 
of the ephrinA2- EphA2 balance. The bidirectional signalling between 
ephrins and Ephs is a result of the activation of different signalling 
pathways in both ligand- and receptor- expressing cells.29 Class A eph-
rin/Eph families are also expressed in various bone cells and regulate 
bone remodelling. For example, EphA4 may contribute to ossifica-
tion by functioning in osteoblasts and hypertrophic chondrocytes.34 
EphA4 and EphA2 are both potential receptors for ephrinA2, but 
F IGURE  3 Protein expression of 
ephrinA2- EphA2 and ephrinB2- EphB4 
(A) in periodontal ligament fibroblasts 
stimulated with 0.1 μg/mL Porphyromonas 
gingivalis LPS as determined by western 
blot. Band densities (B- E) were measured 
by ImageJ software. Data were presented 
as mean±SD. ***P<.001 vs control. LPS, 
lipopolysaccharide
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EphA2 is likely to be preferred among osteoclast precursors during 
early differentiation.9 In this case, the ephrinA2- EphA2 interaction 
facilitates the initiation phase of bone remodelling by enhancing os-
teoclast differentiation and suppressing osteoblast differentiation. 
Both reverse ephrinA2 signalling and forward EphA2 signalling en-
hance osteoclast differentiation, but it is suppressed only by forward 
signalling via EphA2.9 We found that reverse ephrinA2 signalling was 
promoted at an earlier time point in LPS- stimulated PDLFs and was 
followed by forward EphA2 signalling at a later stage upon LPS chal-
lenge. We assume that the overexpression of ephrinA2 reverse sig-
nalling that increases bone resorption is initially promoted and then 
has a reciprocal interaction with the repression of bone formation via 
EphA2 forward signalling. Western blot analysis confirmed the LPS- 
stimulated production of ephrinA2- EphA2 in PDLFs.
In contrast, P. gingivalis LPS decreased EphB4 expression at the 
transcriptional level at 12 and 24 hours but had no significant effect 
on ephrinB2. The interaction of ephrinB2- EphB4 related to bone re-
modelling is mainly investigated in the coupling communication be-
tween osteoclasts and osteoblasts. Zhao et al.8 proposed two- way 
communication between the ephrinB2 ligand on osteoclasts and 
EphB4 receptor on osteoblasts, ie, generating bidirectional signal-
ling when in contact with each other, ephrinB2 and EphB4 transmit 
biological signals into both ephrinB2- expressing cells and EphB4- 
expressing cells. Through an in- vitro study, Zhao et al. found that for-
ward signalling via EphB4 enhances osteoblast formation, whereas 
reverse signalling via ephrinB2 inhibits osteoclast formation. They 
also generated EphB4 transgenic mice, indicating that the overex-
pression of EphB4 in osteoblasts enhances bone formation and sup-
presses bone resorption in vivo. There is also evidence that blocking 
ephrinB2- EphB4 interaction inhibits mineralization in osteoblasts.35 
Tonna et al.36 even ascribed the influence of ephrinB2 in the promo-
tion of osteoblast differentiation to its limiting effect on cell apopto-
sis. Bone homeostasis requires the activities of bone marrow- derived 
mesenchymal stem cells, among which the bidirectional communi-
cation of ephrinB2 and EphB4 signalling has been reported to play 
a crucial role. For example, overexpression of ephrinB2 in mesen-
chymal stem cells displays enhanced osteogenesis and mineralization 
via its interaction with EphB4.37 Moreover, the ephrinB2- stimulated 
forward signalling through EphB4 enhances osteogenic differentia-
tion via cross- talk with the Wnt pathway.38 Unlike ephrinB2, which 
interacts with multiple Ephs, EphB4 only binds to ephrinB2.39 That is 
to say, the decrease of cell surface EphB4 expression suggests sup-
pression of forward signalling via EphB4 activities. Because EphB4 
forward signalling is considered to stimulate osteoblast differen-
tiation,8 its downregulation in PDLFs after treatment with P. gingi-
valis LPS may be associated with the inhibition of bone formation. 
Furthermore, the decreased transcriptional expression of EphB4 
and the opposite change of ephrinA2 have a synergistic effect on 
bone resorption in the early stages. It is interesting that along with 
the insignificant change in EphB4 by 48 hours, the ephrinA2- EphA2 
interaction began to have a major effect on the regulation of bone 
homeostasis, as both ephrinA2 and EphA2 mRNA were upregulated 
by 48 hours. Figure 5 shows the variations of ephrin/Eph signalling 
in PDLFs upon P. gingivalis LPS stimulation. However, these data 
are not consistent with those of a previous study conducted in an 
osteoblast- osteoclast co- culture system treated with P. gingivalis 
LPS, which promoted EphB4 but attenuated ephrinB2 expression.31 
Namely, in the co- culture system, P. gingivalis LPS might contribute to 
the promotion of EphB4- mediated osteoblast differentiation and the 
inhibition of ephrinB2- related osteoclast differentiation. However, it 
seems that in PDLFs, P. gingivalis LPS exerts a negative role in osteo-
blastogenesis through decreasing EphB4 expression. In addition, this 
discrepancy may be due to the different behaviour between the PDL 
and alveolar bone. The protein expression of ephrinB2 and EphB4 
showed a similar pattern with mRNA levels, although some differ-
ences were observed in the treatment time points; ie, the EphB4 
protein level was suppressed in the later stages compared with the 
F IGURE  4 Effects of 0.1 μg/mL Porphyromonas gingivalis 
lipopolysaccharide on the expression of osteoclastogenesis- related 
factors (RANKL and OPG) and osteoblastic markers (ALP, OCN and 
Runx2) in periodontal ligament fibroblasts determined by quantitative 
reverse transcription- polymerase chain reaction when cells were 
treated with 0.1 μg/mL P. gingivalis lipopolysaccharide for 24 h. Data 
were presented as mean±SD. **P<.01, ***P<.001 vs control. ALP, 
alkaline phosphatase; OCN, osteocalcin; OPG, osteoprotegerin; 
RANKL, receptor activator of nuclear factor kappa- B ligand; Runx2, 
runt- related transcription factor 2
F IGURE  5 Variations of ephrin/Eph signalling in periodontal 
ligament fibroblasts upon Porphyromonas gingivalis lipopolysaccharide 
stimulation
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mRNA level, probably due to the lag between transcription and 
translation.
It has been reported that applying compressive force induces the 
expression of ephrinA2- EphA2 and reduces that of ephrinB2- EphB4 
in PDLFs.11 The bone resorption on the compression side during or-
thodontic tooth movement is mediated by the ephrin/Eph system. 
In our research on LPS- stimulated PDLFs, ephrinA2- EphA2 and 
ephrinB2- EphB4 showed changing trends similar to that in the study 
on compressive force,11 which suggests that ephrin/Eph can also be 
modulated by an inflammatory reaction and affects the regulation of 
bone remodelling.
To gain a more profound profile about the behaviour of PDLFs 
under inflammatory challenge, we also stimulated the cells with the 
optimal concentration (0.1 μg/mL) of P. gingivalis LPS for 24 hours, 
which is the same condition as the evaluation of ephrin/Eph signal-
ling, and assessed the mRNA expression of osteogenic and osteoclas-
togenic genes. The interplay between RANKL and RANK is critical 
for osteoclast formation and can also enhance osteoclast activity. 
The OPG receptor, other than RANKL functioning as an osteoclast 
differentiation factor, is an osteoclastogenesis inhibitory factor that 
can also combine with RANK to prevent a RANK- RANKL interaction 
and the consequent bone resorption. RANKL and OPG are related to 
periodontal disease, and a balance between them is essential in bone 
destruction processes.40 In this study, the ephrin/Eph system was 
modulated by P. gingivalis LPS challenge with a concurrent significant 
decrease in the RANKL/OPG ratio, which is in accordance with the 
report14 that the stimulation of PDLFs with LPS leads to increased 
RANKL expression. The results emphasize that ephrinA2- EphA2 and 
ephrinB2- EphB4 might exert a biological effect on LPS- induced in-
flammatory bone destruction. The challenge of ephrinA2- Fc has been 
demonstrated to downregulate the expression of Runx2 and ALP in 
PDLFs.11 Furthermore, EphB4 knockdown in osteoblasts displayed a 
lowered ALP activity.8 In the present study, the mRNA expression of 
Runx2 and osteocalcin was significantly downregulated, which sug-
gests that the regulation of ephrins and Ephs in our setting might be 
responsible for the suppression of osteogenesis. It has been shown 
that the expression of Runx2 and osteocalcin in LPS- treated osteo-
blasts is significantly suppressed,41 which is consistent with the pres-
ent study.
To date, the P. gingivalis LPS has been demonstrated to regulate 
the expression of proinflammatory cytokines through activating toll- 
like receptor (TLR) - 2 or TLR- 4,42 while LPS from other gram- negative 
bacteria is TLR- 1. The TLR- 2 activity of P. gingivalis LPS is ascribed to 
the result of lipoprotein contamination.43 The P. gingivalis LPS used in 
the present study was a commercial preparation purified by the sup-
plier and has undergone enzymatic treatment to remove lipoproteins 
so that TLR- 2 is not activated according to the manufacturer’s instruc-
tions. Whether TLR- 4 is dependent on the modulation of ephrin/Eph 
signalling needs further investigation in our future studies on the path-
way regarding to ephrin/Eph signalling.
Positive regulation by means of enhancing the expression or 
negative regulation through attenuating the expression of ephrins 
or Ephs, and the determination of bone resorption activity, which is 
used to elucidate the functional consequences, were not performed 
in this study and will be investigated in a future study.In conclu-
sion, the expression of ephrinA2- EphA2 significantly increased and 
that of EphB4 decreased in PDLFs upon stimulation with P. gingi-
valis LPS. These changes occurred with a corresponding expressive 
variation in the osteoblast differentiation genes (Runx2 and osteo-
calcin) and osteoclastogenesis- related genes (OPG and RANKL), 
indicating that ephrinA2- EphA2 and ephrinB2- EphB4 interaction 
might regulate inflammatory bone resorption. The results of this 
study will shed light on the development of therapeutic interven-
tions on periodontitis.
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